Clostridium difficile vaccine; Clostridioides difficile vaccine
Jump to navigation
Jump to search
Indications
- investigational prevention of C difficile colitis
Dosage
- 4 dose series: 0, 1, 6 & 12 monts
Mechanism of action
- antibody elicited to inactivated C difficile toxin A & C difficile toxin B
More general terms
References
- ↑ Remich S et al. A phase 2 extension study evaluating the immunogenicity, safety, and tolerability of 3 or 4 doses of a Clostridioides difficile vaccine in healthy US adults 65 to 85 years of age. J Infect Dis 2023 Aug 2; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37531657 https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiad307/7235954